Leaving the study early · adults with panic disorder
It is very uncertain whether all psychological therapies changes dropouts for any reason compared with antidepressants alone or antidepressants and benzodiazepines (very low certainty).
1 finding from 1 review
Long‐term remission/response · adults with panic disorder
1 finding from 1 review
Short‐term improvement Scale used (range; lower is better): panic frequency Clinical Global Impression (1 to 7) Agoraphobic Cognitive Questionnaire (1 to 70) Fear Questionnaire Agoraphobia Subscale (0 to 14) Brief Scale for Anxiety (0 to 60) STAI ... · adults with panic disorder
1 finding from 1 review
Short‐term remission · adults with panic disorder
All psychological therapies showed no clear difference in short‐term remission compared with tricyclic antidepressants (low certainty).
1 finding from 1 review
Short‐term response · adults with panic disorder
All psychological therapies showed no clear difference in short‐term response compared with tricyclic antidepressants (low certainty).
1 finding from 1 review
Leaving the study early · adults with panic disorder
All psychological therapies showed no clear difference in dropouts for any reason compared with tricyclic antidepressants (low certainty).
1 finding from 1 review
Long‐term remission/response · adults with panic disorder
1 finding from 1 review
Leaving the study early · patients with the treatment of cocaine dependence
Amantidine showed no clear difference in dropouts compared with antidepressants (moderate certainty).
1 finding from 1 review
Risk for at least one adverse event per patient · patients with the treatment of cocaine dependence
Amantidine showed no clear difference in adverse events as N of participants with at least one adverse event compared with antidepressants (low certainty).
1 finding from 1 review
Abstinence · patients with the treatment of cocaine dependence
Amantidine may leads to lower abstinence (objective) N of subjects abstinent at the end of the study compared with antidepressants (low certainty).
1 finding from 1 review
Headache duration (hours) · patients with tension‐type headache
1 finding from 1 review
Symptomatic/analgesic medication use for acute headache attacks · patients with tension‐type headache
1 finding from 1 review
Headache index · patients with tension‐type headache
1 finding from 1 review
Quality of life · patients with tension‐type headache
1 finding from 1 review
no estimate extracted
Studies not reported
Low
Withdrawals due to adverse events · patients with tension‐type headache
SSRIs or SNRIs showed no clear difference in withdrawals due to adverse events compared with other antidepressants (low certainty).
1 finding from 1 review
Headache (frequency) · patients with tension‐type headache
1 finding from 1 review
Headache intensity (mean score) · patients with tension‐type headache
1 finding from 1 review
Occlusal splint vs Pharmacological interventions (benzodiazepines, anticonvulsants, beta blockers, dopamine agents, antidepressants, botulinum toxin A and B, analgesics)
Outcome not reported · People with sleep bruxism (tooth grinding or clenching); children (greater than 1 year old) and adults; diagnosis clinical,…
The review found no eligible studies for this question.
1 finding from 1 review
Smoking cessation · people who smoke
Bupropion leads to higher smoking cessation (at least six months of compared with placebo/no pharmacological treatment (high certainty).
1 finding from 1 review
Serious adverse events · people who smoke
Bupropion showed no clear difference in serious adverse events compared with placebo/no pharmacological treatment (moderate certainty).
1 finding from 1 review